A perspective on standardizing the predictive power of noninvasive cardiovascular tests by likelihood ratio computation: 1. Mathematical principles

Authors
Citation
Am. Weissler, A perspective on standardizing the predictive power of noninvasive cardiovascular tests by likelihood ratio computation: 1. Mathematical principles, MAYO CLIN P, 74(11), 1999, pp. 1061-1071
Citations number
9
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
MAYO CLINIC PROCEEDINGS
ISSN journal
00256196 → ACNP
Volume
74
Issue
11
Year of publication
1999
Pages
1061 - 1071
Database
ISI
SICI code
0025-6196(199911)74:11<1061:APOSTP>2.0.ZU;2-M
Abstract
The current practice of reporting positive and negative predictive value (P V), sensitivity (Se), and specificity (Sp) as measures of the power of noni nvasive cardiovascular tests has significant limitations. A test result's P V and its comparison with other test results are highly dependent on the pr etest disease prevalence at which it is determined; the citation of sensiti vity and specificity provides no succinct or explicit quantitation of the r ule-in and rule-out power of a test. This article presents a rationale for the use of an alternative standard for expressing predictive power in the f orm of positive and negative likelihood ratios, (+)LR and (-)LR. The likeli hood ratios are composite expressions of test power, which incorporate the Se and Sp and their respective complements [(1-Se) and (1-Sp)], thus yieldi ng single unambiguous measures of positive and negative predictive power. T he likelihood ratios are calculated as follows: (+)LR = Se/(1-Sp) and (-)LR = Sp/(1-Se). On analysis of the predictive value equations, the likelihood ratios equal the quotients of the posttest predictive value odds to the pr etest prevalence odds for disease and no disease, respectively, as follows: (+)LR = (+)PVOd/POD and (-)LR = (-)PVOn/PON, where (+)PVOd is positive pre dictive value odds for disease, POD is prevalence odds for disease, (-)PVOn is negative predictive value odds for no disease, and PON is prevalence od ds for no disease. Thus, the likelihood ratios are measures of the odds adv antage in posttest probability of disease or no disease relative to pretest probability, independent of disease prevalence in the tested population. T he quotients of the (+)LR or the (-)LR among test results studied in a comm on population are direct expressions of their relative predictive power in that population. The likelihood ratio principle is applicable to the evalua tion of the predictive power of multiple tests performed in a common popula tion and to estimating predictive power at multiple test thresholds.